• Medicare Program: Proposed changes to the Hospital Outpatient Prospective Payment System and CY 2009 Payment Rates; Proposed changes to the Ambulatory Surgical Center Payment System and CY 2009 Payment Rates. Medicare Program: Revisions to payment policies under the Physician Fee Schedule and other revisions to Part B for CY 2009. Direct to Consumer Marketing Practices.
• Medicare Program: Proposed changes to the Hospital Outpatient Prospective Payment System and CY 2009 Payment Rates; Proposed changes to the Ambulatory Surgical Center Payment System and CY 2009 Payment Rates. Medicare Program: Revisions to payment policies under the Physician Fee Schedule and other revisions to Part B for CY 2009.
• H.R.2138, The Investment in America Act of 2007; S.41, The Research Competitiveness Act of 2007; H.R.1424, the Emergency Economic Stabalization Act

Duration: January 1, 2008 to December 31, 2008

General Issues: Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Medical/Disease Research/Clinical Labs, Pharmacy

Spending: about $200,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: House of Representatives, U.S. Senate, Executive Office of the President (EOP), Office of Management & Budget (OMB), Health & Human Services - Dept of (HHS)